Fig. 3From: A novel tumor doubling time-related immune gene signature for prognosis prediction in hepatocellular carcinomaVerification of this signature in ICGC and clinical cohort. A Distribution of risk scores, OS status, and gene expression profiles in ICGC. B Kaplan–Meier survival plot in ICGC. C Characteristics in ROC analysis for predicting 1, 2, and 3-year OS rates in ICGC. D Distribution of risk scores, OS status, and gene expression profiles clinical cohort. E Kaplan–Meier survival plot clinical cohort. F Characteristics in ROC analysis for predicting 1, 2, and 3-year OS rates clinical cohortBack to article page